IRVINE, Calif., March 11 -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Cowen and Company Annual Healthcare Conference at the Marriott Copley Place Hotel in Boston on Tuesday, March 18, 2008.
Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer & treasurer, is scheduled to speak to conference attendees at 11:00 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations. The company's global brands, which are sold in approximately 100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com/.
Source: Edwards Lifesciences Corporation
Media, Amanda Fowler,
Investors, David K. Erickson,
both of Edwards Lifesciences Corporation
Web site: http://www.edwards.com/